# 2026-19541: Lab Wants to Bulk-Produce Pot Extracts, DEA Says OK?

2026-19541, Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-09-24, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before November 23, 2026. Such persons may also file a written request for a hearing on the application on or before November 23, 2026. (as of 2026-10-01).

- Canonical: https://policyrisk.com/federal-register/2026-19541
- As of: 2026-10-01
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19541
- Title: Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 60649
- Published: 2026-09-24
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before November 23, 2026. Such persons may also file a written request for a hearing on the application on or before November 23, 2026.
- Comments close: 2026-11-23
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-10-01

## In one line

Lab Wants to Bulk-Produce Pot Extracts, DEA Says OK?

## Summary

Eli-Elsohly Laboratories wants to become a big-time maker of certain controlled substances like marijuana extracts and some strong medicines. People and companies involved with these drugs can share their thoughts or ask for a hearing by November 23, 2026. This move could impact drug supply and research, but no costs or changes to users are expected right now.

## Abstract

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-19541 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/24/2026-19541/bulk-manufacturer-of-controlled-substances-application-eli-elsohly-laboratories)
- [2026-19541 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-24/pdf/2026-19541.pdf)

## Related
- [Previous: 2026-19540, Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (…](https://policyrisk.com/federal-register/2026-19540)
- [Next: 2026-19542, Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company](https://policyrisk.com/federal-register/2026-19542)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19541 (as of 2026-10-01).